YD Bio Ltd (YDES) Balance Sheet
As of 2025-12-31 (20-F), YD Bio Ltd (YDES) reported total assets of $13.8M, total liabilities of $16.6M and shareholders' equity of -$2.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $6.0M. Long-term debt: $6764.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
YDESYD Bio LtdFollow YDES — free
—
Price chart with a free account
- Market cap
- 350.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- —
| Line | FY2024 Dec 24 | FY2025 Dec 25 | Latest Dec 25 | Trend |
|---|---|---|---|---|
| Cash and equivalents | 3.1 | 6.0 | 6.0 | |
| Receivables | 0.1 | 0.2 | 0.2 | |
| Inventory | 0.0 | 1.9 | 1.9 | |
| Current assets | 3.5 | 9.7 | 9.7 | |
| Total assets | 6.9 | 13.8 | 13.8 | |
| Current liabilities | 0.3 | 1.6 | 1.6 | |
| Long-term debt | — | 0.0 | 0.0 | |
| Total liabilities | 0.3 | 16.6 | 16.6 | |
| Shareholders' equity | 6.6 | -2.9 | -2.9 |
USD millions · SEC XBRL
YD Bio Ltd — questions
- How much cash does YD Bio Ltd have?
- $6.0M in cash and cash equivalents as of 2025-12-31.
- How much debt does YD Bio Ltd have?
- $6764 of long-term debt as of 2025-12-31.
- What are YD Bio Ltd's total assets?
- $13.8M as of 2025-12-31.
- What is YD Bio Ltd's shareholders' equity?
- -$2.9M as of 2025-12-31.
Every figure on this page comes from YD Bio Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.